Lina Badimon Selected Research

N- (N- gamma- L- glutamyl- 2- amino- 2- (4- (4- S- nitrosomercapto- 1- methylpiperidine)acetyl)glycine)

3/2004

Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lina Badimon Research Topics

Disease

50	Atherosclerosis 01/2022 - 01/2003
47	Thrombosis (Thrombus) 01/2022 - 03/2003
36	Inflammation (Inflammations) 02/2022 - 05/2006
34	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2005
28	Atherosclerotic Plaque (Atheroma) 11/2021 - 09/2002
26	Myocardial Infarction 01/2022 - 03/2006
12	ST Elevation Myocardial Infarction 11/2022 - 01/2014
10	Hemorrhage 01/2021 - 09/2007
10	Hypercholesterolemia 10/2020 - 09/2002
10	Hypoxia (Hypoxemia) 08/2015 - 05/2008
9	Heart Failure 11/2022 - 01/2017
9	Acute Coronary Syndrome 11/2022 - 03/2004
9	Ischemia 02/2022 - 01/2007
7	Hypertension (High Blood Pressure) 01/2022 - 06/2008
7	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 05/2021 - 04/2015
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 03/2004
7	Infarction (Infarctions) 01/2020 - 03/2011
6	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2007
6	Fibrosis (Cirrhosis) 12/2018 - 03/2011
6	Wounds and Injuries (Trauma) 06/2014 - 01/2003
5	Cicatrix (Scar) 01/2020 - 09/2012
5	Obesity 07/2017 - 08/2010
5	Stroke (Strokes) 01/2015 - 01/2007
5	Necrosis 12/2013 - 01/2008
4	Reperfusion Injury 01/2020 - 03/2011
4	Ischemic Stroke 01/2020 - 11/2013
4	Vascular System Injuries 01/2020 - 02/2008
4	Vascular Diseases (Vascular Disease) 01/2019 - 08/2009
4	Type 2 Diabetes Mellitus (MODY) 09/2018 - 04/2013
4	Myocardial Ischemia (Ischemic Heart Diseases) 12/2017 - 04/2007
4	Rupture 05/2011 - 03/2006
3	COVID-19 01/2022 - 01/2021
3	Ventricular Remodeling 01/2021 - 10/2014
3	Disease Progression 01/2021 - 01/2017
3	Peripheral Arterial Disease 01/2021 - 01/2015
3	Neoplasms (Cancer) 12/2020 - 02/2008
3	Hyperlipidemias (Hyperlipidemia) 01/2020 - 08/2005
3	Overweight 09/2018 - 05/2015
3	Dyslipidemias (Dyslipidemia) 09/2018 - 04/2012
3	Acute-Phase Reaction 01/2017 - 10/2013
3	Insulin Resistance 10/2014 - 04/2012
3	Pathologic Constriction (Stenosis) 01/2012 - 11/2005

Drug/Important Bio-Agent (IBA)

43	LipidsIBA 01/2022 - 11/2005
31	Proteins (Proteins, Gene)FDA Link 02/2022 - 03/2003
25	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
17	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022 - 11/2005
14	oxidized low density lipoproteinIBA 01/2020 - 09/2002
10	Lipoproteins (Lipoprotein)IBA 05/2021 - 04/2012
10	LDL CholesterolIBA 01/2021 - 11/2005
9	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 04/2004
9	C-Reactive ProteinIBA 01/2020 - 05/2006
8	LDL Receptors (LDL Receptor)IBA 01/2022 - 02/2010
8	CholesterolIBA 01/2022 - 11/2005
8	Pharmaceutical PreparationsIBA 11/2020 - 05/2008
8	CollagenIBA 01/2020 - 07/2004
8	Thromboplastin (Tissue Factor)IBA 07/2017 - 01/2007
8	Messenger RNA (mRNA)IBA 06/2015 - 11/2004
7	Biological ProductsIBA 02/2022 - 01/2012
7	HDL LipoproteinsIBA 10/2020 - 04/2012
7	Cholesterol Esters (Cholesteryl Esters)IBA 07/2017 - 06/2011
7	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 08/2015 - 03/2005
6	CytokinesIBA 12/2021 - 01/2008
6	EnzymesIBA 01/2018 - 05/2004
5	ProteomeIBA 02/2022 - 09/2014
5	fibrin fragment D (D-dimer)IBA 01/2022 - 07/2006
5	Triglycerides (Triacylglycerol)IBA 05/2021 - 10/2012
5	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2012
5	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 01/2016
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 03/2004
5	Matrix Metalloproteinases (MMPs)IBA 10/2014 - 07/2006
4	HDL CholesterolIBA 01/2022 - 04/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2012
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2008
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2018 - 05/2008
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2015 - 03/2008
4	Simvastatin (Zocor)FDA LinkGeneric 08/2014 - 08/2005
4	Caspase 3 (Caspase-3)IBA 08/2014 - 09/2009
4	Transcription Factors (Transcription Factor)IBA 01/2013 - 01/2003
3	ClusterinIBA 01/2022 - 01/2011
3	Fibrinogen (Factor I)FDA Link 01/2022 - 07/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2008
3	AMP-Activated Protein KinasesIBA 01/2020 - 11/2016
3	Phytosterols (Plant Sterols)IBA 01/2019 - 05/2015
3	CalciumIBA 01/2019 - 05/2011
3	TicagrelorIBA 12/2018 - 11/2016
3	Clopidogrel (Plavix)FDA Link 12/2018 - 07/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 05/2006
3	low density lipoprotein inhibitorIBA 01/2017 - 08/2005
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2016 - 05/2006
3	erucylphosphocholineIBA 01/2015 - 01/2007
3	VLDL LipoproteinsIBA 10/2014 - 05/2011
3	FibrinIBA 02/2008 - 07/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 01/2003
2	AntioxidantsIBA 01/2022 - 10/2017

Therapy/Procedure

29	Therapeutics 11/2022 - 04/2007
6	Percutaneous Coronary Intervention 01/2019 - 09/2007
4	Secondary Prevention 01/2022 - 12/2011
3	Oral Administration 01/2020 - 11/2011
3	Stents 07/2017 - 09/2007
2	Mediterranean Diet 01/2022 - 02/2010